Back to search
ALK or ROS1-positive NSCLC
Clinical trial pipeline · Data from ClinicalTrials.gov
See which ALK or ROS1-positive NSCLC trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which ALK or ROS1-positive NSCLC trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This phase I trial studies the side effects and best dose of ceritinib and everolimus in treating patients with solid tumors that have spread from where they st…
The objective of this study is to assess the efficacy of the combination of Platinum (carboplatin or cisplatin), Pemetrexed, Atezolizumab+/- Bevacizumab if elig…